Linical Co., Ltd.
JPX: 2183.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kazuhiro Hatano
- Employees
- 662
- Headquarters
- Osaka, Japan
- IPO year
- 2008
- Market cap
- ¥5.5B
- Website
- https://www.linical.co.jp
Loading 2183…
Loading profile data…Frequently asked questions about 2183
What does Linical Co., Ltd. (2183.T) do?
Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides cli...
Where does 2183.T trade?
Linical Co., Ltd. (2183.T) trades on the Tokyo Stock Exchange.
What sector is 2183.T in?
Linical Co., Ltd. (2183.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Linical Co., Ltd.?
Kazuhiro Hatano is the chief executive officer of Linical Co., Ltd. (2183.T).
Where is Linical Co., Ltd. headquartered?
Linical Co., Ltd. is headquartered in Japan.
Does 2183.T pay a dividend?
Yes — Linical Co., Ltd. (2183.T) paid a trailing twelve-month dividend of JPY 8.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 2183.T go public?
Linical Co., Ltd. (2183.T) completed its initial public offering in 2008.